Retraction Note: Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer

Min Soo Kim¹, Joon Jeong², Jeongbeob Seo³, Hae-Suk Kim⁴, Seong-Jin Kim⁵, Wook Jin^{6

7}

Affiliations

¹ Laboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, GachonUniversity, Incheon, 406-840, Korea.
² Department of Surgery, Gangnam Severance Hospital, Yonsei University Medical College, 712 Eonjuro, Gangnam-Gu, Seoul, 135-720, Korea.
³ Medicinal Chemistry, CMG Pharma, 335, CHA Bio Complex, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Korea.
⁴ TheragenEtex Bio Institute, TheragenEtex Co., Suwon, Gyeonggi-do, 16229, Republic of Korea.
⁵ Nano-Bio Medicine Research Center, Advanced Institutes of Convergence Technology, and Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Suwon, Kyunggi-do, 16229, Republic of Korea. jasonsjkim@snu.ac.kr.
⁶ Laboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, GachonUniversity, Incheon, 406-840, Korea. jinwo@gachon.ac.kr.
⁷ Gachon Medical Research Institute, Gil Medical Center, Incheon, 405-760, Korea. jinwo@gachon.ac.kr.

Min Soo Kim et al. Sci Rep. 2025.

. 2025 Sep 29;15(1):33319.

doi: 10.1038/s41598-025-18790-5.

Min Soo Kim¹, Joon Jeong², Jeongbeob Seo³, Hae-Suk Kim⁴, Seong-Jin Kim⁵, Wook Jin^{6

7}

¹ Laboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, GachonUniversity, Incheon, 406-840, Korea.
² Department of Surgery, Gangnam Severance Hospital, Yonsei University Medical College, 712 Eonjuro, Gangnam-Gu, Seoul, 135-720, Korea.
³ Medicinal Chemistry, CMG Pharma, 335, CHA Bio Complex, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Korea.
⁴ TheragenEtex Bio Institute, TheragenEtex Co., Suwon, Gyeonggi-do, 16229, Republic of Korea.
⁵ Nano-Bio Medicine Research Center, Advanced Institutes of Convergence Technology, and Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Suwon, Kyunggi-do, 16229, Republic of Korea. jasonsjkim@snu.ac.kr.
⁶ Laboratory of Molecular Disease and Cell Regulation, Department of Biochemistry, School of Medicine, GachonUniversity, Incheon, 406-840, Korea. jinwo@gachon.ac.kr.
⁷ Gachon Medical Research Institute, Gil Medical Center, Incheon, 405-760, Korea. jinwo@gachon.ac.kr.

No abstract available

Retraction of

Dysregulated JAK2 expression by TrkC promotes metastasis potential, and EMT program of metastatic breast cancer.
Kim MS, Jeong J, Seo J, Kim HS, Kim SJ, Jin W. Kim MS, et al. Sci Rep. 2016 Sep 22;6:33899. doi: 10.1038/srep33899. Sci Rep. 2016. Retraction in: Sci Rep. 2025 Sep 29;15(1):33319. doi: 10.1038/s41598-025-18790-5. PMID: 27654855 Free PMC article. Retracted.

1. Kim M., Lee W., Jeong J., Kim S. & Jin W. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer. Oncotarget. 6, 40158–40171. 10.18632/oncotarget.5522 (2015). - PMC - PubMed